Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Marimed (MRMD) Short-Term Debt issuances (2017 - 2020)

Marimed has reported Short-Term Debt issuances over the past 4 years, most recently at -$158301.0 for Q3 2020.

  • Quarterly Short-Term Debt issuances fell 146.76% to -$158301.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $817295.0 through Sep 2020, up 592.91% year-over-year, with the annual reading at $1.2 million for FY2019, 641.92% up from the prior year.
  • Short-Term Debt issuances was -$158301.0 for Q3 2020 at Marimed, down from $177143.0 in the prior quarter.
  • Over five years, Short-Term Debt issuances peaked at $3.2 million in Q3 2017 and troughed at -$3.4 million in Q4 2017.
  • The 4-year median for Short-Term Debt issuances is -$38745.5 (2018), against an average of $49325.4.
  • The largest YoY upside for Short-Term Debt issuances was 4943.6% in 2019 against a maximum downside of 3677.85% in 2019.
  • A 4-year view of Short-Term Debt issuances shows it stood at -$3.4 million in 2017, then skyrocketed by 99.37% to -$21451.0 in 2018, then soared by 4943.6% to $1.0 million in 2019, then crashed by 115.24% to -$158301.0 in 2020.
  • Per Business Quant, the three most recent readings for MRMD's Short-Term Debt issuances are -$158301.0 (Q3 2020), $177143.0 (Q2 2020), and -$240547.0 (Q1 2020).